Cargando…
Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study
BACKGROUND: The platelet concentrates had been pioneered to be used in regenerative medicine since above a decade. AIMS AND OBJECTIVES: To compare the autologous platelet rich fibrin (PRF) and titanium prepared platelet rich fibrin (T-PRF) in the treatment of infrabony defects, clinically and radiog...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906909/ https://www.ncbi.nlm.nih.gov/pubmed/31849402 http://dx.doi.org/10.4103/jisp.jisp_562_18 |
_version_ | 1783478447519039488 |
---|---|
author | Mitra, Dipika Kalyan Potdar, Priyanka Nandkumar Prithyani, Saurabh Suresh Rodrigues, Silvia Victor Shetty, Gaurav Prabhakar Talati, Meenakshi Abhay |
author_facet | Mitra, Dipika Kalyan Potdar, Priyanka Nandkumar Prithyani, Saurabh Suresh Rodrigues, Silvia Victor Shetty, Gaurav Prabhakar Talati, Meenakshi Abhay |
author_sort | Mitra, Dipika Kalyan |
collection | PubMed |
description | BACKGROUND: The platelet concentrates had been pioneered to be used in regenerative medicine since above a decade. AIMS AND OBJECTIVES: To compare the autologous platelet rich fibrin (PRF) and titanium prepared platelet rich fibrin (T-PRF) in the treatment of infrabony defects, clinically and radiographically and to compare the histologic difference between PRF and T-PRF by light microscopy and scanning electron microscopy (SEM). MATERIALS AND METHODS: The present study is a split mouth randomised controlled trial study in which 20 sites were selected and randomly assigned equally into 10 sites each in group A [Test group=T-PRF] and group B [Control group=PRF]. Clinical parameters were evaluated at baseline,3 months and 9 months. Radiographic parameters were evaluated at baseline and 9 months. Histologic differences between light microscopy and SEM for both PRF and T-PRF was studied after sequential processing. RESULTS: There was marked reduction in Probing Pocket depth and gain in Clinical Attachment Level in both the T-PRF and PRF groups from baseline to 9 months in intragroup comparisons. However, on intergroup comparisons, no statistical significance was seen. Radiographically, mean defect depths for both the groups showed statistically significant reduction from baseline values to 9 months on intragroup comparisons but not on intergroup comparisons. In-vitro evaluation, on both light and scanning electron microscopy, T-PRF showed denser fibril meshwork as compared to PRF. CONCLUSION: The clinical parameters and radiographic outcomes showed marked improvement at 9 months with both PRF and T-PRF in the treatment of infrabony defects from baseline values in intragroup comparison. However, statistically efficacy of T-PRF was not seen to be superior to that of PRF both clinically and radiographically. Histologic evaluation showed T-PRF had denser fibrils as compared to PRF in both light and scanning electron microscopy. |
format | Online Article Text |
id | pubmed-6906909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-69069092019-12-17 Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study Mitra, Dipika Kalyan Potdar, Priyanka Nandkumar Prithyani, Saurabh Suresh Rodrigues, Silvia Victor Shetty, Gaurav Prabhakar Talati, Meenakshi Abhay J Indian Soc Periodontol Original Article BACKGROUND: The platelet concentrates had been pioneered to be used in regenerative medicine since above a decade. AIMS AND OBJECTIVES: To compare the autologous platelet rich fibrin (PRF) and titanium prepared platelet rich fibrin (T-PRF) in the treatment of infrabony defects, clinically and radiographically and to compare the histologic difference between PRF and T-PRF by light microscopy and scanning electron microscopy (SEM). MATERIALS AND METHODS: The present study is a split mouth randomised controlled trial study in which 20 sites were selected and randomly assigned equally into 10 sites each in group A [Test group=T-PRF] and group B [Control group=PRF]. Clinical parameters were evaluated at baseline,3 months and 9 months. Radiographic parameters were evaluated at baseline and 9 months. Histologic differences between light microscopy and SEM for both PRF and T-PRF was studied after sequential processing. RESULTS: There was marked reduction in Probing Pocket depth and gain in Clinical Attachment Level in both the T-PRF and PRF groups from baseline to 9 months in intragroup comparisons. However, on intergroup comparisons, no statistical significance was seen. Radiographically, mean defect depths for both the groups showed statistically significant reduction from baseline values to 9 months on intragroup comparisons but not on intergroup comparisons. In-vitro evaluation, on both light and scanning electron microscopy, T-PRF showed denser fibril meshwork as compared to PRF. CONCLUSION: The clinical parameters and radiographic outcomes showed marked improvement at 9 months with both PRF and T-PRF in the treatment of infrabony defects from baseline values in intragroup comparison. However, statistically efficacy of T-PRF was not seen to be superior to that of PRF both clinically and radiographically. Histologic evaluation showed T-PRF had denser fibrils as compared to PRF in both light and scanning electron microscopy. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6906909/ /pubmed/31849402 http://dx.doi.org/10.4103/jisp.jisp_562_18 Text en Copyright: © 2019 Indian Society of Periodontology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Mitra, Dipika Kalyan Potdar, Priyanka Nandkumar Prithyani, Saurabh Suresh Rodrigues, Silvia Victor Shetty, Gaurav Prabhakar Talati, Meenakshi Abhay Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study |
title | Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study |
title_full | Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study |
title_fullStr | Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study |
title_full_unstemmed | Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study |
title_short | Comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: An in vitro and in vivo study |
title_sort | comparative study using autologous platelet-rich fibrin and titanium prepared platelet-rich fibrin in the treatment of infrabony defects: an in vitro and in vivo study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906909/ https://www.ncbi.nlm.nih.gov/pubmed/31849402 http://dx.doi.org/10.4103/jisp.jisp_562_18 |
work_keys_str_mv | AT mitradipikakalyan comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy AT potdarpriyankanandkumar comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy AT prithyanisaurabhsuresh comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy AT rodriguessilviavictor comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy AT shettygauravprabhakar comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy AT talatimeenakshiabhay comparativestudyusingautologousplateletrichfibrinandtitaniumpreparedplateletrichfibrininthetreatmentofinfrabonydefectsaninvitroandinvivostudy |